Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Takeshi Iidaka is active.

Publication


Featured researches published by Takeshi Iidaka.


Japanese Journal of Cancer Research | 2001

Differential Effects of Partial Hepatectomy and Carbon Tetrachloride Administration on Induction of Liver Cell Foci in a Model for Detection of Initiation Activity

Hiroki Sakai; Tetsuya Tsukamoto; Masami Yamamoto; Norimitsu Shirai; Takeshi Iidaka; Tokuma Yanai; Toshiaki Masegi; Masae Tatematsu

Differential effects of partial hepatectomy (PH) and carbon tetrachloride (CC14) administration on induction of glutathione S‐transferase placental form (GST‐P)‐positive foci were investigated in a model for detection of initiation activity. Firstly, we surveyed cell proliferation kinetics and fluctuation in cytochrome P450 (CYP) mRNA levels by means of relative‐quantitative real‐time reverse transcriptase‐polymerase chain reaction (RT‐PCR) and CYP 2E1 apoprotein amount by immuno‐blotting (experiment I) after PH or CC14 administration. Next, to assess the interrelationships among cell proliferation, fluctuation of CYPs after PH or CC14 administration and induction of liver cell foci, the non‐hepatocarcinogen, 1,2‐dimethylhydrazine (DMH) was administered to 7‐week‐old male F344 rats and initiated populations were selected using the resistant hepatocyte model (experiment II). In experiment I, the values of all CYP isozyme mRNAs after PH or CC14 administration were drastically decreased at the 12‐h tune point. From 72 h, mRNAs for all CYP isozymes began increasing, with complete recovery after 7 days. The CYP 2E1 apoprotein content in the PH group fluctuated weakly, whereas in the CC14 group it had decreased rapidly after 12 h and was still low at the 48 h point. In experiment II, induction of GST‐P‐positive foci was related to cell kinetics in the PH group, with about a 6‐h time lag between tune for carcinogen administration giving greatest induction of GST‐P‐positive foci and peaks in bromodeoxyuridine (BrdU) labeling, presumably due to the necessity for bioactivation of DMH. With CC14 administration, induction of foci appeared dependent on the recovery of CYP 2E1. In conclusion, PH was able to induce cell proliferation with maintenance of CYP 2E1, therefore being advantageous for induction of liver cell foci in models to detect initiation activity.


Cancer Letters | 2002

Summation of initiation activities in the liver after partial hepatectomy

Hiroki Sakai; Tetsuya Tsukamoto; Masami Yamamoto; Akihiro Hirata; Atsushi Inagami; Norimitsu Shirai; Takeshi Iidaka; Tokuma Yanai; Toshiaki Masegi; Masae Tatematsu

Summation of initiation activities of different carcinogens in the liver after partial hepatectomy (PH) was investigated with reference to induction of glutathione S-transferase placental form (GST-P) positive foci. Firstly, effects of repeated administration of 1,2-dimethylhydradine (DMH) were compared with the results of a single administration of the same total dose (Expt. I). Subsequently, we studied summation of initiation potential with serial administration of DMH with diethylnitrosamine (DEN) or N-bis (2-hydroxpropyl)-nitrosamine (DHPN). In Expt. I, induction of GST-P-positive foci by multiple low-dose administration was equal to that with the single large-dose treatment. In order to avoid toxicity in hepatectomized rats, the low repeated-dose approach appeared superior. In Expt. II, the numbers of GST-P-positive foci in the groups treated with DMH plus DHPN or DMH plus DEN were significantly higher than those in the groups receiving the carcinogens singly. It is concluded that there is summation of initiation potential with doses of a single or multiple carcinogens. These results suggest that the present initiation assay model is useful to investigate summation of initiation activities of various environmental chemicals.


Journal of Comparative Pathology | 2002

Proliferative Activity of Canine Mast Cell Tumours Evaluated by Bromodeoxyuridine Incorporation and Ki-67 Expression

Hiroki Sakai; Ayako Noda; Norimitsu Shirai; Takeshi Iidaka; Tokuma Yanai; Toshiaki Masegi


Carcinogenesis | 2002

Elevated susceptibility of the p53 knockout mouse esophagus to methyl-N-amylnitrosamine carcinogenesis.

Norimitsu Shirai; Tetsuya Tsukamoto; Masami Yamamoto; Takeshi Iidaka; Hiroki Sakai; Tokuma Yanai; Toshiaki Masegi; Lawrence A. Donehower; Masae Tatematsu


Experimental Animals | 2007

Correlation among Clinicopathological Parameters of Myocardial Damage in Rats Treated with Isoproterenol

Masaaki Kurata; Takeshi Iidaka; Yukiko Sasayama; Tamio Fukushima; Masanori Sakimura; Norimitsu Shirai


Journal of Cancer Research and Clinical Oncology | 2003

High susceptibility of nullizygous p53 knockout mice to colorectal tumor induction by 1,2-dimethylhydrazine

Hiroki Sakai; Tetsuya Tsukamoto; Masami Yamamoto; Norimitsu Shirai; Takeshi Iidaka; Akihiro Hirata; Tokuma Yanai; Toshiaki Masegi; Lawrence A. Donehower; Masae Tatematsu


Journal of Toxicological Sciences | 2007

SIMULTANEOUS MEASUREMENT OF NUCLEATED CELL COUNTS AND CELLULAR DIFFERENTIALS IN RAT BONE MARROW EXAMINATION USING FLOW CYTOMETER

Masaaki Kurata; Takeshi Iidaka; Yoshimasa Hamada; Ikuo Horii


Cancer Letters | 2005

Lack of elevated liver carcinogenicity of aminophenylnorharman in p53-deficient mice

Takeshi Iidaka; Tetsuya Tsukamoto; Yukari Totsuka; Akihiro Hirata; Hiroki Sakai; Norimitsu Shirai; Masami Yamamoto; Keiji Wakabayashi; Tokuma Yanai; Toshiaki Masegi; Lawrence A. Donehower; Masae Tatematsu


Journal of Toxicologic Pathology | 2002

Tongue Carcinogenic Susceptibility of p53 Deficient Mice to Methyl-n-amylnitrosamine

Norimitsu Shirai; Tetsuya Tsukamoto; Masami Yamamoto; Takeshi Iidaka; Hiroki Sakai; Tokuma Yanai; Toshiaki Masegi; Lawrence A. Donehower; Masae Tatematsu


Experimental Animals | 2005

Battery of tests for profiling abnormalities of vitamin K-dependent coagulation factors in drug-toxicity studies in rats.

Masaaki Kurata; Takeshi Iidaka; Naoko Yamasaki; Yukiko Sasayama; Yoshimasa Hamada

Collaboration


Dive into the Takeshi Iidaka's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Masaaki Kurata

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge